These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29738814)

  • 1. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous Immunization with Recombinant
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Rep Biochem Mol Biol; 2019 Jan; 7(2):196-203. PubMed ID: 30805400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I; Fisher AN; Rappuoli R; Davis SS; Illum L
    Vaccine; 1998 Dec; 16(20):2039-46. PubMed ID: 9796062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein.
    Lee SF; Halperin SA; Salloum DF; MacMillan A; Morris A
    Infect Immun; 2003 Apr; 71(4):2272-5. PubMed ID: 12654855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.
    Jinyong Z; Xiaoli Z; Weijun Z; Ying G; Gang G; Xuhu M; Quanming Z
    Mol Biol Rep; 2011 Mar; 38(3):1957-63. PubMed ID: 20878241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.
    Olivera N; Castuma CE; Hozbor D; Gaillard ME; Rumbo M; Gómez RM
    Biomed Res Int; 2014; 2014():421486. PubMed ID: 24982881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
    Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.
    Alonso S; Reveneau N; Pethe K; Locht C
    Infect Immun; 2002 Aug; 70(8):4142-7. PubMed ID: 12117922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin.
    Hussein AH; Davis EM; Halperin SA; Lee SF
    Infect Immun; 2007 Nov; 75(11):5476-82. PubMed ID: 17724067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development.
    Zhang R; Duan G; Shi Q; Chen S; Fan Q; Sun N; Xi Y
    Biotechnol Lett; 2016 Nov; 38(11):1911-1916. PubMed ID: 27406731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
    Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein.
    Keil DJ; Burns EH; Kisker WR; Bemis D; Fenwick B
    Vaccine; 1999 Dec; 18(9-10):860-7. PubMed ID: 10580199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.
    Zhao Z; Xue Y; Wu B; Tang X; Hu R; Xu Y; Guo A; Chen H
    Infect Immun; 2008 May; 76(5):2157-63. PubMed ID: 18268026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.
    Mielcarek N; Nordström I; Menozzi FD; Locht C; Holmgren J
    Infect Immun; 2000 Feb; 68(2):485-91. PubMed ID: 10639408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.